Theranos is now "on life support"; we make sense of the state of innovation of blood diagnostics
February 17, 2017 | Analyst Insight
It was back in June of 2016 when Forbes had revised its valuation of Theranos from $4.5 billion to $0 following a series of investigations and allegations that the company's blood...
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.